MWR
TEVA icon

McAdams Wright Ragen’s Teva Pharmaceuticals TEVA Stock Holding History

McAdams Wright Ragen’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$35M Sell
651,443
-6,945
-1% -$368K 1.96% 7
2014
Q2 		$34.5M Buy
658,388
+26,618
+4% +$1.36M 1.93% 11
2014
Q1 		$33.4M Buy
631,770
+190,230
+43% +$8.79M 2.07% 9
2013
Q4 		$17.7M Buy
441,540
+414,815
+1,552% +$16.3M 1.17% 21
2013
Q3 		$1.01M Sell
26,725
-6,878
-20% -$268K 0.08% 163
2013
Q2 		$1.32M Buy
+33,603
New +$1.31M 0.11% 150

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

McAdams Wright Ragen's TEVA Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Teva Pharmaceuticals (TEVA) stake by 1.1% in Q3 2014, selling an estimated $368K and leaving 651,443 shares worth $35M. The position accounts for 1.96% of the portfolio, ranked #7.

McAdams Wright Ragen first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • McAdams Wright Ragen held 651,443 shares of Teva Pharmaceuticals worth $35M as of Q3 2014.
  • McAdams Wright Ragen sold 6,945 Teva Pharmaceuticals shares in Q3 2014, an estimated $368K.
  • Teva Pharmaceuticals made up 1.96% of McAdams Wright Ragen's portfolio in Q3 2014, its #7 holding.
  • McAdams Wright Ragen first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.